Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of UV-4B in Healthy Subjects
NCT02696291Phase 1Terminated
- Sponsor
- Emergent BioSolutions
- Start
- May 2016
- Primary completion
- Mar 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of UV-4B in dengue fever and viral infection (6 arms), sponsored by Emergent BioSolutions. Primary endpoints: Treatment-emergent Adverse Events, Serious Adverse Events and 1 more. Started May 2016; status: terminated.
02
Drugs
UV-4B
03
Conditions
dengue feverviral infection
Beyond the preview
Go deeper on NCT02696291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02696291.